Back to mobile site
Get it on Google Play

Acrivon presents preclinical data on drug combinations at AACR

April 17, 2026 4:00 PM EDT Send to a Friend
Acrivon Therapeutics (NASDAQ: ACRV) announced preclinical data showing synergies between its drug candidates and cancer treatments at the AACR 2026 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login